Transcept Pharmaceuticals Profit Margin Quarterly:
-7047% for Dec. 31, 2012Transcept Pharmaceuticals Historical Profit Margin Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -7047% |
| Sept. 30, 2012 | 46.50% |
| June 30, 2012 | -1043% |
| March 31, 2012 | |
| Dec. 31, 2011 | 41.31% |
| Sept. 30, 2011 | -798.6% |
| June 30, 2011 | -71.87% |
| March 31, 2011 | -62.05% |
| Dec. 31, 2010 | -84.26% |
| Sept. 30, 2010 | -88.54% |
| June 30, 2010 | -65.95% |
| March 31, 2010 | -58.94% |
| Dec. 31, 2009 | -75.01% |
| Sept. 30, 2009 | -182.7% |
| June 30, 2009 | |
| March 31, 2009 | |
| Dec. 31, 2008 | |
| Sept. 30, 2008 | -7399% |
| June 30, 2008 | 87.67% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatile earnings. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
TSPT Profit Margin Quarterly Benchmarks
| Companies | |
|---|---|
| Cleveland BioLabs | |
| Vertex Pharmaceuticals | -93.80% |
| Achillion Pharmaceuticals |
TSPT Profit Margin Quarterly Rankings
| Overall |
38th percentile 4925 of 8005 |
| Sector |
26th percentile 505 of 686 in Healthcare |
| Industry |
43rd percentile 139 of 248 in Biotechnology |
TSPT Profit Margin Quarterly Range, Past 5 Years
| Minimum | -7399% | Sep 2008 |
| Maximum | 87.67% | Jun 2008 |
| Average | -1120% |
